(Q37867946)

24 August 2017

1 reference

title

Oxidative stress and endothelial dysfunction in hypertension (English)

1 reference

24 August 2017

0 references

arterial hypertension

0 references

oxidative stress

0 references

author name string

Eberhard Schulz

series ordinal

1

1 reference

24 August 2017

Tommaso Gori

series ordinal

2

1 reference

24 August 2017

Thomas Münzel

series ordinal

3

1 reference

24 August 2017

publication date

21 April 2011

1 reference

24 August 2017

published in

Hypertension Research

1 reference

24 August 2017

volume

34

1 reference

24 August 2017

issue

6

1 reference

24 August 2017

page(s)

665-673

1 reference

https://scigraph.springernature.com/pub.10.1038/hr.2011.39

24 August 2017

exact match

0 references

cites work

2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

State-of-the-Art lecture. Role of endothelin-1 in hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Endothelium-dependent contractions and endothelial dysfunction in human hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Impact of the components of metabolic syndrome on oxidative stress and enzymatic antioxidant activity in essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Relationship between oxidative stress and essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Endothelial function and oxidative stress in renovascular hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Irbesartan, an angiotensin type 1 receptor inhibitor, regulates the vascular oxidative state in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Antioxidant effects and the therapeutic mode of action of calcium channel blockers in hypertension and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Vascular oxidative stress precedes high blood pressure in spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Effect of chronic N-acetylcysteine treatment on the development of spontaneous hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Effect of YC-1, an NO-independent, superoxide-sensitive stimulator of soluble guanylyl cyclase, on smooth muscle responsiveness to nitrovasodilators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Activation of soluble guanylate cyclase by carbon monoxide and inhibition by superoxide anion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Endothelial nitric oxide synthase in vascular disease: from marvel to menace

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Pathophysiology, diagnosis and prognostic implications of endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Vascular consequences of endothelial nitric oxide synthase uncoupling for the activity and expression of the soluble guanylyl cyclase and the cGMP-dependent protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Formation and properties of peroxynitrite as studied by laser flash photolysis, high-pressure stopped-flow technique, and pulse radiolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Superoxide production and expression of nox family proteins in human atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia: enhancement by angiotensin II

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Role of reduced lipoic acid in the redox regulation of mitochondrial aldehyde dehydrogenase (ALDH-2) activity. Implications for mitochondrial oxidative stress and nitrate tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

The role of endothelium in human hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Impaired endothelial function in arterial hypertension and hypercholesterolemia: potential mechanisms and differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Conduit artery constriction mediated by low flow a novel noninvasive method for the assessment of vascular function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Reduction of peripheral flow reserve impairs endothelial function in conduit arteries of patients with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Endothelial function and common carotid artery wall thickening in patients with essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Interrelations between brachial endothelial function and carotid intima-media thickness in young adults: the cardiovascular risk in young Finns study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Flow-mediated vasodilation and the risk of developing hypertension in healthy postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Prognostic significance of endothelial dysfunction in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Interaction between vascular dysfunction and cardiac mass increases the risk of cardiovascular outcomes in essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

NADPH oxidases: functions and pathologies in the vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Upregulation of vascular NAD(P)H oxidase subunit gp91phox and impairment of the nitric oxide signal transduction pathway in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Nox1 is involved in angiotensin II-mediated hypertension: a study in Nox1-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Nox1 overexpression potentiates angiotensin II-induced hypertension and vascular smooth muscle hypertrophy in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Opposing roles of p47phox in basal versus angiotensin II-stimulated alterations in vascular O2- production, vascular tone, and mitogen-activated protein kinase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Telmisartan improves vascular function independently of metabolic and antihypertensive effects in hypertensive subjects with impaired glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Improvement of endothelial function in patients with hypertension and type 2 diabetes after treatment with telmisartan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Fixed combination of perindopril and indapamide at low dose improves endothelial function in essential hypertensive patients after acute administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Telmisartan improves endothelial function in patients with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Treatment of essential arterial hypertension with enalapril does not result in normalization of endothelial dysfunction of the conduit arteries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Endothelial regulation of vasomotion in apoE-deficient mice: implications for interactions between peroxynitrite and tetrahydrobiopterin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Upregulation of renal and vascular nitric oxide synthase in young spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Mechanisms underlying endothelial dysfunction in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Transcriptional and posttranscriptional regulation of endothelial nitric oxide synthase expression by hydrogen peroxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Direct measurement of nitric oxide generation from nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Upregulation of Nox1 in vascular smooth muscle leads to impaired endothelium-dependent relaxation via eNOS uncoupling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Improvement of impaired endothelial function by tetrahydrobiopterin in stroke-prone spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Tetrahydrobiopterin enhances forearm vascular response to acetylcholine in both normotensive and hypertensive individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Stoichiometric relationships between endothelial tetrahydrobiopterin, endothelial NO synthase (eNOS) activity, and eNOS coupling in vivo: insights from transgenic mice with endothelial-targeted GTP cyclohydrolase 1 and eNOS overexpression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Interactions of peroxynitrite, tetrahydrobiopterin, ascorbic acid, and thiols: implications for uncoupling endothelial nitric-oxide synthase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

The ratio between tetrahydrobiopterin and oxidized tetrahydrobiopterin analogues controls superoxide release from endothelial nitric oxide synthase: an EPR spin trapping study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Endothelial dihydrofolate reductase: critical for nitric oxide bioavailability and role in angiotensin II uncoupling of endothelial nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Augmented BH4 by gene transfer restores nitric oxide synthase function in hyperglycemic human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Increased endothelial tetrahydrobiopterin synthesis by targeted transgenic GTP-cyclohydrolase I overexpression reduces endothelial dysfunction and atherosclerosis in ApoE-knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Discovery of common human genetic variants of GTP cyclohydrolase 1 (GCH1) governing nitric oxide, autonomic activity, and cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Endothelium-specific GTP cyclohydrolase I overexpression attenuates blood pressure progression in salt-sensitive low-renin hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Tetrahydrobiopterin improves endothelium-dependent vasodilation in chronic smokers : evidence for a dysfunctional nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Folates and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

High glucose via peroxynitrite causes tyrosine nitration and inactivation of prostacyclin synthase that is associated with thromboxane/prostaglandin H(2) receptor-mediated apoptosis and adhesion molecule expression in cultured human aortic endotheli

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells: involvement of S-adenosylmethionine-dependent methyltransferases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

ADMA and oxidative stress are responsible for endothelial dysfunction in hyperhomocyst(e)inemia: effects of L-arginine and B vitamins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Cardiovascular effects of systemic nitric oxide synthase inhibition with asymmetrical dimethylarginine in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Oxidative stress increases endothelin-1 synthesis in human coronary artery smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Downregulation of soluble guanylyl cyclase in young and aging spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Reduction of the soluble cyclic GMP vasorelaxing system in the vascular wall of stroke-prone spontaneously hypertensive rats: effect of the alpha1 -receptor blocker doxazosin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Dysfunction of soluble guanylyl cyclase in aorta and kidney of Goto-Kakizaki rats: influence of age and diabetic state

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Association of mitochondrial SOD deficiency with salt-sensitive hypertension and accelerated renal senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Redox signaling (cross-talk) from and to mitochondria involves mitochondrial pores and reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Molecular mechanisms of angiotensin II-mediated mitochondrial dysfunction: linking mitochondrial oxidative damage and vascular endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Therapeutic targeting of mitochondrial superoxide in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Does superoxide underlie the pathogenesis of hypertension?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Xanthine oxidase activity associated with arterial blood pressure in spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

A mechanism of oxygen free radical production in the Dahl hypertensive rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Xanthine oxidase and mitochondria contribute to vascular superoxide anion generation in DOCA-salt hypertensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

5-Methyltetrahydrofolate, the Active Form of Folic Acid, Restores Endothelial Function in Familial Hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Folic Acid Reverts Dysfunction of Endothelial Nitric Oxide Synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Enhanced expression of angiotensin-converting enzyme is associated with progression of coronary atherosclerosis in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

A Specific Role for eNOS-Derived Reactive Oxygen Species in Atherosclerosis Progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Prognostic role of reversible endothelial dysfunction in hypertensive postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

Identification of a cytochrome P450 2C9-derived endothelium-derived hyperpolarizing factor in essential hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

7 January 2021

Oxidative stress in malignant and non-malignant phase hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

7 January 2021

Carvedilol inhibits reactive oxygen species generation by leukocytes and oxidative damage to amino acids

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

7 January 2021

Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

7 January 2021

Central role of mitochondrial aldehyde dehydrogenase and reactive oxygen species in nitroglycerin tolerance and cross-tolerance.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

7 January 2021

Peroxynitrite formed by simultaneous generation of nitric oxide and superoxide selectively inhibits bovine aortic prostacyclin synthase

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

7 January 2021

Oxidation of the zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

7 January 2021

Impaired endothelium-dependent vasodilation in patients with essential hypertension: evidence that the abnormality is not at the muscarinic receptor level

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

7 January 2021

Impaired endothelium-dependent vasodilation in patients with essential hypertension. Evidence that nitric oxide abnormality is not localized to a single signal transduction pathway

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

7 January 2021

Urinary albumin excretion is associated with impaired flow- and nitroglycerin-mediated brachial artery dilatation in hypertensive adults

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

7 January 2021

Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

7 January 2021

Flow-mediated constriction: further insight into a new measure of vascular function

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

7 January 2021

Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

7 January 2021

Increased NAD(P)H oxidase-mediated superoxide production in renovascular hypertension: evidence for an involvement of protein kinase C

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

7 January 2021

Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: potential implications for inflammation and plaque instability

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

7 January 2021

Large and small artery endothelial function in patients with essential hypertension--effect of ACE inhibition and beta-blockade

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

7 January 2021

Native low-density lipoprotein increases endothelial cell nitric oxide synthase generation of superoxide anion

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

7 January 2021

Effect of native and oxidized low-density lipoprotein on endothelial nitric oxide and superoxide production : key role of L-arginine availability

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

7 January 2021

Superoxide anion production is increased in a model of genetic hypertension: role of the endothelium

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

7 January 2021

Overexpression of endothelial nitric oxide synthase accelerates atherosclerotic lesion formation in apoE-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

7 January 2021

Asymmetrical dimethylarginine, an endogenous nitric oxide synthase inhibitor, in experimental hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

7 January 2021

Upregulation of p67(phox) and gp91(phox) in aortas from angiotensin II-infused mice

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

7 January 2021

Oxidative stress increases synthesis of big endothelin-1 by activation of the endothelin-1 promoter

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

7 January 2021

Contribution of the renin-angiotensin system to subsensitivity of soluble guanylyl cyclase in TGR(mREN2)27 rats

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

7 January 2021

Hydralazine prevents endothelial dysfunction, but not the increase in superoxide production in nitric oxide-deficient hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

7 January 2021

Angiotensin II induces endothelial xanthine oxidase activation: role for endothelial dysfunction in patients with coronary disease

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

7 January 2021

Xanthine oxidase inhibition with oxypurinol improves endothelial vasodilator function in hypercholesterolemic but not in hypertensive patients

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

7 January 2021

Allopurinol Normalizes Endothelial Dysfunction in Type 2 Diabetics With Mild Hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

7 January 2021

Nitric oxide-dependent endothelial function is unaffected by allopurinol in hypercholesterolaemic subjects

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

7 January 2021

Increased kidney xanthine oxidoreductase activity in salt-induced experimental hypertension

1 reference

https://api.crossref.org/works/10.1038%2FHR.2011.39

7 January 2021

Identifiers

DOI

10.1038/HR.2011.39

1 reference

Dimensions Publication ID

24 August 2017

1021258792

0 references

1 reference